Lanx impressive portfolio is made up of numerous "me too" products along with their flagship product, the ASPEN. Fortunately, they are backed by numerous investors which should help Mike develop a strategic plan in executing and taking the company to the next level. Some of Mike's challenges will be to develop the business distribution model with younger direct sales reps. This model may weigh in on the investors patience, considering that it will take more time to ramp up sales in other product segments. If ASPEN accounts for more than 60% of revenue, it will take time, consulting contracts, and realistic expectations as to the time it will take to elevate this company to the next level.
The biggest challenge will be overcoming a reputation within the industry that this is a half-assed operation. Product innovation will not come from Mike, it will come from a creative and experienced research and development team. In closing we wish Mike well and suggest that he not surround himself with all his former MEED friends. It will take out of the box thinking in the current economic and healthcare environment for this company to really thrive. Good Night and Good Luck Mike!